Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:25 AM
Ignite Modification Date:
2025-12-25 @ 1:25 AM
NCT ID:
NCT06348693
Eligibility Criteria:
Inclusion Criteria:
* Patients with glioma diagnosed histologically confirmed (WHO) undergoing surgical resection;
* hypomethylation or hypermethylation of MGMT assessed post-surgery for patients affected by GBM;
* adult patients (≥18 years), both sexes;
* Patients undergoing Stupp protocol including patients aged \> 70 years performing the hypofractionated protocol and three weeks of chemotherapy;
* Karnofsky Performance Status (KPS)\> 60 assessed post-surgery;
* freely given written informed consent prior to any activity related to the study. erine
Exclusion Criteria:
* patients who do not sign the informed consent
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT06348693
Study Brief:
Protocol Section:
NCT06348693